Ranking Profile - Quanterix Corp
Introduction
Quanterix Corp (Quanterix) is a life sciences company that develops and markets an ultra-sensitive digital immunoassay platform. It offers a biomarker detection system, antibodies and ELISA kits, a bead-based immunoassay platform and homebrew assays. Quanterix provides protein biomarker testing and custom assay development services. It markets diagnostics technology under the brands of Simoa, HD-X Analyzer, SR-X, SP-X Imaging and Analysis System and Uman NF-Light. Its products find application in detecting central nervous system (CNS), oncology, and cardiac biomarkers at ultra-low levels; measuring inflammatory markers in normal and disease samples, and cytokine levels and profiles in non-critical and critical COVID-19 patients. The company operates in the Netherlands, Sweden, Hong Kong and China. Quanterix is headquartered in Billerica, Massachusetts, the US.
Company info
Country (HQ): | United States |
Sector: | Medical Equipment |
Market Cap (US$ m): | 685 |
Revenue (US$ m): | 106 (2022) |
Innovation ranking
Innovation score
Closest peers in the Medical Equipment sector
Innovation Ranking
Medtronic Plc
Ireland
Medical Equipment
Boston Scientific Corp
United States
Medical Equipment
Quanterix Corp
United States
Medical Equipment
Savara Inc
United States
Medical Equipment
Aethlon Medical Inc
United States
Medical Equipment
Are you ranked? Get the Innovation Ranking Report
-
Company Ranking Report
- If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
- Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
- Contextualised information on the company's standing in relation to peers
- Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
- Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
- Rosettes
- Certificate of Achievement
- Press release